Medical Aspects of Chemical Warfare (2008) - The Black Vault
Medical Aspects of Chemical Warfare (2008) - The Black Vault Medical Aspects of Chemical Warfare (2008) - The Black Vault
Medical Management of Chemical Toxicity in Pediatricsmortality among children. 6In the 1990s the Japanese Aum Shinrikyo cult manufacturedand used nerve agents to target civilians ofMatsumoto and Tokyo (see Chapter 4). 24,26–28,32,34 In 1995the Aum deployed the nerve agent sarin in a Tokyosubway attack, and approximately 5,000 people, rangingfrom 3 to 86 years old, sought medical attention. 32Around the same time, the Federal Bureau of Investigationuncovered a terrorist plot to release a chlorinegas bomb at Disneyland. 32 These events confirm thatchemical weapons pose a threat to the US pediatricpopulation.GENERAL PRINCIPLES OF CHEMICAL EXPOSUREChemical weapons include nerve agents, vesicatingor blistering agents, choking or pulmonaryirritants, cyanides, vomiting agents, incapacitatingagents, and riot control agents. 35 The most importantagents used for terrorism are nerve agents (tabun,sarin, soman, VX), vesicants (mustards, lewisite),pulmonary agents (phosgene, chlorine), and cyanide.Injury from each agent is related to its chemical properties(eg, volatility, persistence), route of entry, anddose. 36 Volatility, or an agent’s tendency to vaporize, isaffected by temperature, wind, and delivery method.Persistence, or the tendency of a liquid agent to remainin the environment, is affected by temperatureand surface texture. The major routes of agent entryare inhalation, cutaneous absorption, ingestion, andinjection. Exposure through inhalation, which oftenoccurs with toxic agents like sarin and chlorine, mayresult in asphyxia, lung damage, and upper airwayobstruction. Their higher metabolic and respiratoryrates put children at increased risk for toxicity afterchemical agent exposure, and their diminutive statureexposes children to toxic agents that concentratecloser to the ground.The extent of an agent’s toxicity is determined by theconcentration of the agent in the air and the amount oftime a person is exposed. Low doses of agent can causesymptoms such as airway irritation, bronchospasm,and increased secretions, exacerbating underlyinglung diseases. High doses can result in airway edema,obstruction, and copious secretions. Direct alveolardamage from pulmonary toxicants, such as chlorineor phosgene, can result in pulmonary edema. Whenmanaging affected patients, it is necessary to anticipatethe need for emergency intubation; children’s smallerairway calibers put them at greater risk for airwayobstruction and lead to more rapid progression of narrowingand impending airway obstruction.Cutaneous exposure affects the eyes and skin, andcorrosive chemicals can cause ischemic necrosis thatresults in small vessel thrombosis, especially in theeyes. Acidic or alkali chemical burns can result incoagulation necrosis or liquefaction. Skin absorptioncan lead to systemic toxicity, and when skin is damaged,transepidermal water loss is inevitable. This isespecially concerning because hypovolemic shockcan occur when water loss is excessive. Extensive skinloss, prolonged exposure, and the temperature of thewater used for decontamination can rapidly lead tohypothermia in children, whose surface-to-volumeratio is greater than that of adults.Negative pressure, full-face gas mask use by untrainedcivilians is not a recommended method of preventingchemical toxicity. 37 Gas masks and respiratorsincrease the work of breathing and physiologic deadspace, factors that tend to reduce alveolar ventilation.Also, respirators require a proper fit and filter canistermaintenance to adequately protect users, and canisterintegrity can be altered by handling, water damage,and excessive breathing pressure. In Israel, improperuse of gas masks led to 13 suffocation deaths in adultswhen the filter caps were not removed, and 114 adultdeaths from cardiorespiratory arrest when the maskswere used in sealed rooms. 37In general, managing children exposed to chemicalagents may be challenging. For example, it may be difficultto obtain vascular access in children because theyhave smaller caliber blood vessels than adults. Urinarycatherization may also be challenging. Healthcarepractitioners should be aware of and appropriatelyprepare for these issues by maintaining trained staffand a supply inventory that includes a range of equipmentsizes; because there is no single pediatric size, arange of appropriate pediatric-sized equipment mustbe available.CHALLENGES TO MANAGING PEDIATRIC CHEMICAL CASUALTIESManaging pediatric victims of chemical terrorismis especially difficult. In addition to the obvious physiologicaland anatomical differences between childrenand adults (Table 21-1), there are important psychologicaland behavioral differences that put children at risk. 33Anecdotal reports have claimed that children are likelyto be the first to manifest symptoms, to develop moresevere manifestations, and to be hospitalized for otherrelated illnesses after chemical agent exposure. Children’ssmaller mass reduces the dose of toxic agent needed657
Medical Aspects of Chemical WarfareTable 21-1Pediatric Vulnerabilities and Implications for Clinical ManagementUnique Vulnerability in ChildrenImplications and Impact From Chemical ToxicityBody composition • Larger BSA compared to body mass • Greater dermal absorption• Lower total lipid/fat content• Less partitioning of lipid-soluble componentsVolume status • More prone to dehydration • Can be more symptomatic and show signs of• Chemical agents lead to diarrhea and severe dehydrationvomitingRespiratory • Increased basal metabolic rate compared • Enhanced toxicity via inhalational routeto greater minute volumeBlood• Limited serum protein binding capacity • Potential for greater amount of free toxicant and• Greater cutaneous blood flowgreater distribution• Greater percutaneous absorptionSkin • Thinner epidermis in preterm infants • Increased toxicity from percutaneous absorption• Greater cutaneous blood flowof chemical agentsOrgan size and enzymatic • Larger brain mass• Greater CNS exposurefunction • Immature renal function • Slower elimination of renally cleared toxins,• Immature hepatic enzymeschemicals, and metabolites• Decreased metabolic clearance by hepatic phasei and II reactionsAnatomical • Short stature means breathing occurs • Exposure to chemicals can have significantconsiderations closer to ground where aerosolized impact on bone marrow and developing CNSchemical agents settle• Increased airway narrowing from chemical-• Smaller airwayagent–induced secretions• Greater deposition of fine particles in the • Mustard significantly affects rapidly growingupper airwaytissues• Higher proportion of rapidly growingtissuesCentral nervous system • Higher BBB permeability • Increased risk of CNS damage• Rapidly growing CNSMiscellaneous • Immature cognitive function • Inability to discern threat, follow directions, and• Unable to flee emergencyprotect self• Immature coping mechanisms• High risk for developing PTSDBBB: blood-brain barrierBSA: body surface areaCNS: central nervous systemPTSD: posttraumatic stress disorderto cause observable or lethal effects. Studies involvingorganophosphates (OPs), compounds related to nerveagents, have shown greater vulnerability in immatureanimals than in adults. Some OPs produce the same degreeof lethality in juveniles at a fraction of the dose thatproduces lethality in adults. 33 The increased toxicity seenin children compared to adults from various routes ofexposure can be attributed to a wide variety of factors:• differences in anatomy,• allometric scaling factors (eg, increased surfacearea-to-volume ratio),• cardiovascular status,• permeability of the pediatric blood-brain barrier,• dermatologic factors (eg, increased cutaneousblood flow),• increased skin pH,• plasma protein binding,• volume of distribution,• organ size and maturity, and• pharmacokinetic maturity (eg, metabolicdifferences). 38–42These unique anatomical and physiological featurescause pediatric rates of absorption, distribution, metabolism,and excretion to differ from those of adults.658
- Page 629 and 630: Medical Aspects of Chemical Warfare
- Page 631 and 632: Medical Aspects of Chemical Warfare
- Page 633 and 634: Medical Aspects of Chemical Warfare
- Page 635 and 636: Medical Aspects of Chemical Warfare
- Page 637 and 638: Medical Aspects of Chemical Warfare
- Page 639 and 640: Medical Aspects of Chemical Warfare
- Page 641 and 642: Medical Aspects of Chemical Warfare
- Page 643 and 644: Medical Aspects of Chemical Warfare
- Page 645 and 646: Medical Aspects of Chemical Warfare
- Page 647 and 648: Medical Aspects of Chemical Warfare
- Page 649 and 650: Medical Aspects of Chemical Warfare
- Page 651 and 652: Medical Aspects of Chemical Warfare
- Page 653 and 654: Medical Aspects of Chemical Warfare
- Page 655 and 656: Medical Aspects of Chemical Warfare
- Page 657 and 658: Medical Aspects of Chemical Warfare
- Page 659 and 660: Medical Aspects of Chemical Warfare
- Page 661 and 662: Medical Aspects of Chemical Warfare
- Page 663 and 664: Medical Aspects of Chemical Warfare
- Page 665 and 666: Medical Aspects of Chemical Warfare
- Page 667 and 668: Medical Aspects of Chemical Warfare
- Page 669 and 670: Medical Aspects of Chemical Warfare
- Page 671 and 672: Medical Aspects of Chemical Warfare
- Page 673 and 674: Medical Aspects of Chemical Warfare
- Page 675 and 676: Medical Aspects of Chemical Warfare
- Page 677 and 678: Medical Aspects of Chemical Warfare
- Page 679: Medical Aspects of Chemical Warfare
- Page 683 and 684: Medical Aspects of Chemical Warfare
- Page 685 and 686: Medical Aspects of Chemical Warfare
- Page 687 and 688: Medical Aspects of Chemical Warfare
- Page 689 and 690: Medical Aspects of Chemical Warfare
- Page 691 and 692: Medical Aspects of Chemical Warfare
- Page 693 and 694: Medical Aspects of Chemical Warfare
- Page 695 and 696: Medical Aspects of Chemical Warfare
- Page 697 and 698: Medical Aspects of Chemical Warfare
- Page 699 and 700: Medical Aspects of Chemical Warfare
- Page 701 and 702: Medical Aspects of Chemical Warfare
- Page 703 and 704: Medical Aspects of Chemical Warfare
- Page 705 and 706: Medical Aspects of Chemical Warfare
- Page 707 and 708: Medical Aspects of Chemical Warfare
- Page 709 and 710: Medical Aspects of Chemical Warfare
- Page 711 and 712: Medical Aspects of Chemical Warfare
- Page 713 and 714: Medical Aspects of Chemical Warfare
- Page 715 and 716: Medical Aspects of Chemical Warfare
- Page 717 and 718: Medical Aspects of Chemical Warfare
- Page 719 and 720: Medical Aspects of Chemical Warfare
- Page 721 and 722: Medical Aspects of Chemical Warfare
- Page 723 and 724: Medical Aspects of Chemical Warfare
- Page 725 and 726: Medical Aspects of Chemical Warfare
- Page 727 and 728: Medical Aspects of Chemical Warfare
- Page 729 and 730: Medical Aspects of Chemical Warfare
<strong>Medical</strong> Management <strong>of</strong> <strong>Chemical</strong> Toxicity in Pediatricsmortality among children. 6In the 1990s the Japanese Aum Shinrikyo cult manufacturedand used nerve agents to target civilians <strong>of</strong>Matsumoto and Tokyo (see Chapter 4). 24,26–28,32,34 In 1995the Aum deployed the nerve agent sarin in a Tokyosubway attack, and approximately 5,000 people, rangingfrom 3 to 86 years old, sought medical attention. 32Around the same time, the Federal Bureau <strong>of</strong> Investigationuncovered a terrorist plot to release a chlorinegas bomb at Disneyland. 32 <strong>The</strong>se events confirm thatchemical weapons pose a threat to the US pediatricpopulation.GENERAL PRINCIPLES OF CHEMICAL EXPOSURE<strong>Chemical</strong> weapons include nerve agents, vesicatingor blistering agents, choking or pulmonaryirritants, cyanides, vomiting agents, incapacitatingagents, and riot control agents. 35 <strong>The</strong> most importantagents used for terrorism are nerve agents (tabun,sarin, soman, VX), vesicants (mustards, lewisite),pulmonary agents (phosgene, chlorine), and cyanide.Injury from each agent is related to its chemical properties(eg, volatility, persistence), route <strong>of</strong> entry, anddose. 36 Volatility, or an agent’s tendency to vaporize, isaffected by temperature, wind, and delivery method.Persistence, or the tendency <strong>of</strong> a liquid agent to remainin the environment, is affected by temperatureand surface texture. <strong>The</strong> major routes <strong>of</strong> agent entryare inhalation, cutaneous absorption, ingestion, andinjection. Exposure through inhalation, which <strong>of</strong>tenoccurs with toxic agents like sarin and chlorine, mayresult in asphyxia, lung damage, and upper airwayobstruction. <strong>The</strong>ir higher metabolic and respiratoryrates put children at increased risk for toxicity afterchemical agent exposure, and their diminutive statureexposes children to toxic agents that concentratecloser to the ground.<strong>The</strong> extent <strong>of</strong> an agent’s toxicity is determined by theconcentration <strong>of</strong> the agent in the air and the amount <strong>of</strong>time a person is exposed. Low doses <strong>of</strong> agent can causesymptoms such as airway irritation, bronchospasm,and increased secretions, exacerbating underlyinglung diseases. High doses can result in airway edema,obstruction, and copious secretions. Direct alveolardamage from pulmonary toxicants, such as chlorineor phosgene, can result in pulmonary edema. Whenmanaging affected patients, it is necessary to anticipatethe need for emergency intubation; children’s smallerairway calibers put them at greater risk for airwayobstruction and lead to more rapid progression <strong>of</strong> narrowingand impending airway obstruction.Cutaneous exposure affects the eyes and skin, andcorrosive chemicals can cause ischemic necrosis thatresults in small vessel thrombosis, especially in theeyes. Acidic or alkali chemical burns can result incoagulation necrosis or liquefaction. Skin absorptioncan lead to systemic toxicity, and when skin is damaged,transepidermal water loss is inevitable. This isespecially concerning because hypovolemic shockcan occur when water loss is excessive. Extensive skinloss, prolonged exposure, and the temperature <strong>of</strong> thewater used for decontamination can rapidly lead tohypothermia in children, whose surface-to-volumeratio is greater than that <strong>of</strong> adults.Negative pressure, full-face gas mask use by untrainedcivilians is not a recommended method <strong>of</strong> preventingchemical toxicity. 37 Gas masks and respiratorsincrease the work <strong>of</strong> breathing and physiologic deadspace, factors that tend to reduce alveolar ventilation.Also, respirators require a proper fit and filter canistermaintenance to adequately protect users, and canisterintegrity can be altered by handling, water damage,and excessive breathing pressure. In Israel, improperuse <strong>of</strong> gas masks led to 13 suffocation deaths in adultswhen the filter caps were not removed, and 114 adultdeaths from cardiorespiratory arrest when the maskswere used in sealed rooms. 37In general, managing children exposed to chemicalagents may be challenging. For example, it may be difficultto obtain vascular access in children because theyhave smaller caliber blood vessels than adults. Urinarycatherization may also be challenging. Healthcarepractitioners should be aware <strong>of</strong> and appropriatelyprepare for these issues by maintaining trained staffand a supply inventory that includes a range <strong>of</strong> equipmentsizes; because there is no single pediatric size, arange <strong>of</strong> appropriate pediatric-sized equipment mustbe available.CHALLENGES TO MANAGING PEDIATRIC CHEMICAL CASUALTIESManaging pediatric victims <strong>of</strong> chemical terrorismis especially difficult. In addition to the obvious physiologicaland anatomical differences between childrenand adults (Table 21-1), there are important psychologicaland behavioral differences that put children at risk. 33Anecdotal reports have claimed that children are likelyto be the first to manifest symptoms, to develop moresevere manifestations, and to be hospitalized for otherrelated illnesses after chemical agent exposure. Children’ssmaller mass reduces the dose <strong>of</strong> toxic agent needed657